文献速递药物不良反应与药物警戒特殊人群用药

儿童药物不良反应的因果关系、严重程度与可避免性:11年回顾性综述

Causality, severity and avoidability of adverse drug reactions in children: An 11-year review.
PubMed 文献 · Br J Clin Pharmacol · 2025-11-25

该研究对某四级儿科医院11年间599例0-18岁住院儿童药物不良反应(ADR)进行回顾性分析,采用Naranjo标准、Hartwig量表和改良Schumock和Thornton量表评估因果关系、严重程度与可避免性。结果显示74%为轻度,抗菌药物最常见(46%),15%的ADR潜在可避免(9%肯定可避免,6%可能可避免),主要原因为未考虑过敏史、剂量不当、药物相互作用或未采取预防措施。

要点

  • 儿童ADR以轻度为主(74%),抗菌药物最常见(46%)。
  • 15%的ADR潜在可避免,主要因未考虑过敏史、剂量不当或药物相互作用。
  • A型反应占44%,B型反应占56%,B型最常见于抗菌药物(63%)。

核心结论

  • 六分之一(15%)的儿童ADR潜在可避免,提示需改进ADR记录、药物警戒和临床医生教育。

研究设计与样本

  • 11年回顾性队列研究,纳入0-18岁因ADR入院或住院期间发生ADR的儿童,排除故意药物滥用或过量。
  • 共纳入599例儿童,中位年龄8.7岁(范围3周至18岁)。
  • 采用Naranjo标准评估因果关系,Hartwig量表评估严重程度,改良Schumock和Thornton量表评估可避免性。

主要发现

  • 74%的ADR为轻度,25%为中度,1%为重度。
  • 最常见涉及药物为抗菌药物(46%)、镇痛药(9%)、抗癫痫药(8%)和单克隆抗体(6%)。
  • A型反应占44%,以甲氧氯普胺引起的神经系统症状最常见(22%);B型反应占56%,最常见于抗菌药物(63%)。
  • 15%的ADR潜在可避免:9%肯定可避免,6%可能可避免。
  • 可避免ADR的主要原因包括未考虑已记录的过敏史、剂量不当、药物相互作用或未采取预防措施(如预用药)。

关键数值与推荐

  • 因果关系采用Naranjo标准评估。
  • 严重程度采用Hartwig量表评估。
  • 可避免性采用改良Schumock和Thornton量表评估。
  • ADR分为A型(剂量相关)和B型(特异质)。

临床怎么用

  • 临床应重视儿童用药前过敏史核查、剂量审核和药物相互作用筛查。
  • 对高风险药物(如抗菌药物、甲氧氯普胺)应加强监测和预防措施。
  • 改进ADR记录和药物警戒体系有助于减少可避免的儿童ADR。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Adverse drug reactions (ADRs) are a frequent cause of hospital presentations and confer increased healthcare costs. This study aimed to assess the causality, severity and avoidability of ADRs in hospitalized children. METHODS: This is an 11-year retrospective cohort study of children aged 0-18 years who were either admitted to a quaternary paediatric hospital due to an ADR or who experienced such a reaction during their hospital stay. Those who presented with intentional drug misuse or overdose were excluded. Causality, severity and avoidability were assessed using the Naranjo criteria, Hartwig scale and Modified Schumock and Thornton scale, respectively. ADRs were categorized as Type A (dose-related) or Type B (idiosyncratic). RESULTS: Of 599 children with ADRs, the median age was 8.7 years (3 weeks to 18 years). Most ADRs (74%) were mild, with 25% moderate and 1% severe. The most commonly implicated drugs were antimicrobials (46%), analgesics (9%), antiepileptics (8%) and monoclonal antibodies (6%). Type A reactions comprised 44%, with neurological symptoms to metoclopramide (22%) being the most common. Type B reactions (56%) most commonly occurred with antimicrobials (63%). Overall, 15% of ADRs were potentially avoidable: 9% definitely and 6% probably avoidable. Most avoidable ADRs were due to failure to consider documented allergies, inappropriate dosing, drug interactions or not applying preventative measures (e.g., premedication). CONCLUSION: Our study shows that one in six paediatric ADRs were potentially avoidable, highlighting the need for improved ADR documentation, pharmacovigilance and clinician education.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Gaafar D, Cranswick N, Dimond R, et al. Causality, severity and avoidability of adverse drug reactions in children: An 11-year review. Br J Clin Pharmacol. 2025. PMID: 41288273. doi:10.1002/bcp.70365

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。